# Effectiveness and Safety of Convalescent Plasma Therapy on COVID-19 Patients With Acute Respiratory Distress Syndrome

> **NCT04380935** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Indonesia University** · enrollment: 60 (estimated)

## Conditions studied

- COVID
- Acute Respiratory Distress Syndrome

## Interventions

- **BIOLOGICAL:** Convalescent plasma
- **DRUG:** Standard of care

## Key facts

- **NCT ID:** NCT04380935
- **Lead sponsor:** Indonesia University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-05-18
- **Primary completion:** 2020-10-31
- **Final completion:** 2020-10-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2020-08-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04380935

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04380935, "Effectiveness and Safety of Convalescent Plasma Therapy on COVID-19 Patients With Acute Respiratory Distress Syndrome". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT04380935. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*